Assoc Prof Dr. Tonino Traini | Nanobiotechnology | Best Researcher Award

Published on by Global Nano Awards

Assoc Prof Dr. Tonino Traini | Nanobiotechnology | Best Researcher Award

Assoc Prof Dr. Tonino Traini, University G d’Annunzio of Chieti- Pescara, Italy

Dr. Tonino Traini is an Associate Professor of Medical Sciences at the University “G. d’Annunzio” of Chieti-Pescara, Italy 🇮🇹. With a Ph.D. in Electrical and Computer Engineering, he specializes in Malattie Odontostomatologiche (Diseases of the Oral Cavity and Jaws). Dr. Traini’s extensive research, marked by over 58 articles in the past decade and a notable H-index of 26, focuses on innovative approaches to dental medicine and biotechnology. He is an active member of various scientific societies and has received national recognition for his contributions. His commitment to academic excellence is complemented by his dedication to teaching and mentoring students at both undergraduate and postgraduate levels.

Professional Profile:

Google Scholar

Orcid

🎓 Education:

Dr. Tonino Traini holds a Ph.D. in Odontostomatology Sciences from the University “G. d’Annunzio” Chieti-Pescara, Italy, awarded in 2005. He further specialized in Dental Surgery, earning a Diploma of Specialization from the same institution in 2016. Prior to that, he obtained his Diploma in Dentistry and Dental Prosthesis from the University “G. d’Annunzio” Chieti-Pescara in 1998.

💼 Professional Experience:

Dr. Tonino Traini has been serving as an Associate Professor in the SSD MED/28 department at the University “G. d’Annunzio” Chieti-Pescara, Italy, since 2018. Prior to this role, he worked as a Researcher at the same institution from 2015 to 2018.

🔬 Research Interests:

Dr. Tonino Traini’s expertise encompasses a range of areas within the field of dentistry, with a particular focus on dental materials, digital prosthetic technologies, and the mechanical and microstructural characteristics of dental materials. His research and professional contributions have significantly advanced our understanding of these domains, shedding light on crucial aspects related to the development, application, and performance of dental materials in various clinical contexts

Publication Top Notes:

  1. Title: Direct laser metal sintering as a new approach to fabrication of an isoelastic functionally graded material for manufacture of porous titanium dental implants
    • Year: 2008
    • Citations: 535
  2. Title: A histologic and histomorphometric evaluation of anorganic bovine bone retrieved 9 years after a sinus augmentation procedure
    • Year: 2007
    • Citations: 242
  3. Title: Three-dimensional printed PLA scaffold and human gingival stem cell-derived extracellular vesicles: a new tool for bone defect repair
    • Year: 2018
    • Citations: 221
  4. Title: Friction of conventional and self-ligating brackets using a 10 bracket model
    • Year: 2005
    • Citations: 216
  5. Title: Morphological and Cytofluorimetric Analysis of Adult Mesenchymal Stem Cells Expanded Ex Vivo from Periodontal Ligament
    • Year: 2005
    • Citations: 198

 

 

 

 

 

Sharon Vijayanand | Nanobiotechnology | Best Researcher Award

Published on by Global Nano Awards

Dr. Sharon Vijayanand | Nanobiotechnology | Best Researcher Award

Dr. Sharon Vijayanand, FDA/CBER/OTP/OPPT, United States

🌐💉🔬 Dr. Sharon Vijayanand, a dedicated researcher and pharmaceutical scientist, earned her Ph.D. in Pharmaceutical Sciences from Mercer University, focusing on a groundbreaking pain-free immunization strategy for COVID-19 and influenza. As an ORISE Fellow at the FDA, she explores FcRn-mediated dynamics of anti-SARS CoV-2 IgG. With a rich academic background and extensive experience, including roles as a Graduate Research Assistant and Pharmacy Technician, she has received numerous awards for her impactful contributions. Dr. Vijayanand is a dynamic leader, fostering collaborations in professional organizations like AAPS and Toastmasters, showcasing her commitment to scientific advancement and effective communication. 🏥👩‍🔬🏆

🎓 Education:

Ph.D. in Pharmaceutical Sciences (Jan 2020 – July 2023) from Mercer University College of Pharmacy, Atlanta, GA, USA. Dissertation Title: “Novel Pain-Free Immunization of a Combination Microparticulate Vaccine for COVID-19 and Influenza.” B. Pharm. (Sept 2015 – Sept 2019) from Dr. M.G.R. Medical University, Chennai, TN, India. Thesis Title: “In Silico Molecular Docking Study of Anti-Breast Cancer Molecules Derived from Plants.”

👩‍🔬 Professional Experience:

ORISE Fellow (Jan 2024 – Present) at FDA/CBER/OPT/OPPT, Silver Spring, MD, USA. Researching FcRn-Mediated Dynamics of Anti-SARS CoV-2 IgG. Graduate Research Assistant and Teaching Assistant (Jan 2020 – July 2023) at Mercer University College of Pharmacy, Atlanta, GA, USA. Conducted preclinical testing of micro/nanoparticle-based non-invasive vaccines, resulting in publications and awards. Optimized brain-targeted nanoparticle formulation for seizure therapy (NIH R01 Project). Developed experimental protocols for SARS-CoV-2 and Influenza assays. Mentored junior graduate and Pharm D students. Pharmacy Technician (Dec 2019 – Jan 2022) at CVS Health, Atlanta, GA, USA. Front-line healthcare worker during the COVID-19 pandemic. Undergraduate Thesis Project Team Lead (Sept 2018 – Aug 2019) at Dr. M.G.R. Medical University, Chennai, TN, India. Led a team of 4 for a molecular docking study.

🌐 Professional Affiliations and Leadership Roles:

American Association of Pharmaceutical Sciences (AAPS): Learning Opportunities Manager, AAPS Pharmaceutical Discovery and Preclinical Development Community. Member Engagement Manager, AAPS Women in Pharmaceutical Science Community. Treasurer, Mercer University AAPS Student Chapter. Public Relations Officer, Mercer University AAPS Student Chapter. Toastmaster International (Mercer Smooth Talkers): Secretary and President. Other Affiliations: Student Member, The American Society for Microbiology (ASM). Member, The Honor Society of Phi Kappa Phi.

🏆 Awards and Honors:

Love of Learning Scholarship Award, Phi Kappa Phi. Monroe F. Swilley Jr. Student Research Award, Mercer University. Various awards at AAPS meetings, including Best Abstract and Best Poster Awards. Keynote Speaker at the 2022 AAPS PharmSci 360 meeting.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 60.
  • Citations – 60.
  • h-index – 4.
  • Documents – 15.

A prolific researcher making meaningful contributions to the academic world!

🔬 Research Focus:

🩹💉🔬 Dr. Sharon Vijayanand, based at FDA/CBER/OTP/OPPT in the United States, specializes in developing innovative vaccine delivery platforms. Her impactful research centers on a dual-delivery system using antigen-loaded nanoparticles in dissolving microneedles, garnering 21 citations in 2022. Notably, her work extends to Zika and SARS-CoV-2 vaccines, employing microparticulate and microneedle technologies to induce robust immune responses. With a focus on influenza and gonococcal vaccines, she explores T-cell potential and enhances bacterial clearance. Dr. Vijayanand’s contributions mark a significant advancement in vaccination strategies, employing cutting-edge techniques for targeted and efficient immune response elicitation. 💊👩‍🔬🌐

Publications Top Note:

Dr Sobia Abid | Nanobiotechnology | Best Researcher Award

Published on by Global Nano Awards

Dr Sobia Abid: Nanobiotechnology: Best Researcher Award

Dr Sobia Abid, The islamia university of bahawalpur,  Pakistan

Ms. Sobia Abid has an impressive academic background, including a Bachelor of Science degree (BS) in 2016, a Master of Science degree (MS) in 2019, and a Doctor of Philosophy (PhD) in Zoology in 2023, all from the Islamia University of Bahawalpur. Her research interests span diverse fields such as fisheries, entomology, diversity, and nanotechnology. Notably, she has gained recognition for her scholarly contributions, with 20 publications in internationally recognized journals accredited by the Higher Education Commission (HEC) and an impact factor of 23.75.

With a remarkable track record of both teaching and research, Ms. Sobia Abid has accumulated 6 years of experience in academia. Furthermore, her dedication to mentoring and nurturing young scholars is evident in her supervision of 30 Bachelor of Science (BS) research students and 8 Master of Science (MS) research students. Ms. Sobia Abid’s unwavering commitment to advancing knowledge in the field of Zoology and her outstanding contributions to both academia and research make her an invaluable asset to any institution.

Honor and Awards:

Dr. Sobia Abid has garnered recognition and accolades for her notable contributions in various spheres. She was honored with a certificate for organizing the first virtual webinar on “International Biodiversity Day” at the international level in May 2021, showcasing her commitment to global environmental awareness. Additionally, she received a shield of appreciation for successfully organizing the first annual science models exhibition in December 2021, highlighting her dedication to promoting scientific inquiry and innovation. Dr. Abid was also awarded a shield and certificate for spearheading a community-based blood screening campaign with the development of a mobile application, showcasing her efforts in leveraging technology for healthcare advancements. Furthermore, her expertise in the field of fisheries was recognized with a shield and certificate of honor for her presentation at the Fish Feed and Feeding workshop at Fish Seed Hatchery, Bahawalpur, in 2020. Her organizational skills were acknowledged with a Certificate of Honor for her role as the organizer of the Department of Life Sciences at The Islamia University of Bahawalpur in 2015. Additionally, she showcased her literary talents by winning an essay writing competition at the district level in Bahawalpur in 2012, demonstrating her multifaceted capabilities and commitment to excellence across different domains.

Workshops, Webinars and trainings:

Dr. Sobia Abid’s dedication to professional development is evident through her extensive participation in various workshops, webinars, and training programs. She has continuously sought to enhance her skills and knowledge in research-related areas, showcasing a commitment to staying updated with the latest developments in her field. In 2022, she attended international webinars focusing on effective presentation skills for researchers and research synopsis writing, demonstrating her interest in refining her research communication abilities. Additionally, she engaged in hands-on training sessions on HPLC and permeation analysis at BZU Multan and participated in a national training workshop on ELISA-based diagnostics at the University of Agriculture, Faisalabad. Dr. Abid also attended several webinars addressing diverse topics such as author networks, the editorial process, COVID-19 pandemic impact, and healthy living for hepatitis prevention, showcasing her broad interest in research-related subjects. Furthermore, she has actively participated in workshops and training programs on bio-safety, biodiversity conservation, scientific writing, literature search, and reference management, indicating her comprehensive approach to professional development. Her attendance at international symposiums and workshops on desert ecosystem management highlights her engagement with broader environmental and ecological themes. Dr. Abid’s proactive approach to learning and skill development underscores her dedication to advancing her expertise in research and academia

Conferences:

Dr. Sobia Abid’s active participation in numerous national and international conferences reflects her deep engagement with the field of zoology and its evolving trends. In 2022, she attended the Zoological Emerging Scientific Trends conference, showcasing her commitment to staying abreast of the latest developments in zoological research. She also took part in the 40th Pakistan Congress of Zoology organized by Sindh Agriculture University in December 2021, demonstrating her involvement in prestigious academic gatherings. Dr. Abid’s attendance at the 39th and 38th Pakistan Congress of Zoology, as well as the 2nd International Conference of Applied Zoology, illustrates her consistent engagement with these platforms over the years, highlighting her dedication to advancing her knowledge and expertise in the field. Moreover, her participation in conferences addressing broader topics such as climate change, biodiversity, and zoonotic diseases underscores her interdisciplinary approach to zoological research, showcasing her interest in exploring diverse facets of the discipline. Through her active involvement in these conferences, Dr. Abid has not only contributed to the exchange of knowledge but also enriched her own understanding of zoology’s multifaceted dimensions.

Professional Profiles:

Publications Top Note:

1. Unlocking the potential of phenyl boronic acid functionalized-quercetin nanoparticles: Advancing antibacterial efficacy and diabetic wound healing

2. Revolutionizing Sericulture: Unleashing the Potential of Ascorbic Acid for Optimal Silkworm Well-being and Maximized Silk Production

3. Exploring the Potent Combination of Quercetin−Boronic Acid, Epalrestat, and Urea Containing Nanoethosomal Keratolytic Gel for the Treatment of Diabetic Neuropathic Pain: In Vitro and In Vivo Studies

4.Survival, growth, behavior, hematology and serum biochemistry of mice under different concentrations of orally administered amorphous silica nanoparticle

5.Growth Response in Oryctolagus cuniculus to Selenium Toxicity Exposure Ameliorated with Vitamin E

Suresh Mickymaray | Nanobiotechnology | Best Researcher Award

Published on by Global Nano Awards

Prof. Suresh Mickymaray: Nanobiotechnology: Best Researcher Award

Prof. Suresh Mickymaray, Majmaah University, Saudi Arabia

👨‍🔬 Prof. Suresh Mickymaray is an accomplished Associate Professor with over 25 years of expertise in Diagnostic Microbiology, Molecular Biology, and Clinical Microbiology. Currently serving as Associate Professor at Majmaah University, Saudi Arabia, he is also a Distinguished Adjunct Professor in Molecular Medicine and Diagnostics at Saveetha Dental College, India. Prof. Mickymaray’s extensive career includes roles as an Assistant Professor, Research Scholar, and Microbiologist. He excels in Clinical Diagnostic Microbiology, Molecular Biology, and Hospital Infection Control, showcasing a commitment to excellence in research, teaching, and administration. 🧪🔬

📅 Career Overview:

Associate Professor: Microbiology, College of Science, Majmaah University, Saudi Arabia (Sep 2020 – Present). Distinguished Adjunct Professor: Centre of Molecular Medicine and Diagnostics, Saveetha University, India (Jan 2022 – Present). Assistant Professor: Microbiology, Majmaah University, Saudi Arabia (Jun 2016 – Aug 2020). Assistant Professor: Medical Laboratories, Majmaah University, Saudi Arabia (Aug 2014 – Jun 2016). Head: Microbiology & Molecular Biology, Doctors’ Diagnostic Center, Trichy, India (2012 – Aug 2014). Assistant Professor: Urumu Dhanalakshmi College, Trichy, India (Oct 2010 – Jan 2012). Research Scholar: A.V.V.M Sri Pushpam College, Thanjavur, India (Jun 2006 – Oct 2010). Microbiologist: Doctors’ Diagnostic Centre, Trichy, India (Apr 2004 – May 2006). Associate Microbiologist: Seahorse Hospitals Ltd., Trichy, India (1993 – Jun 2004).

🏆 Accolades and Affiliations:

Ph.D. in Microbiology: Highly Commended, Bharathidasan University, Trichy. Diploma of Fellow Membership: Awarded by All India Institute of Medical Technologists, Kolkata. Member: Indian Initiative for Management of Antibiotic Resistance (IIMR).

🧪 Area of Expertise:

Clinical Microbiology and Molecular Biology: Diagnostic Molecular Biology of infectious diseases (Real-Time PCR). Clinical Mycology, Parasitology, and Virology. Routine and Special Microscopical examination for various pathogens. Culture, Identification, and susceptibility testing. Hospital Infection Control and Sterilization Procedures. Internal quality maintenance and biomedical instruments monitoring.

🎓 Educational Background:

Ph.D. in Microbiology: Immuno-Molecular Diagnosis of HIV/AIDS infections. M.Sc. in Microbiology: Demographic features and opportunistic infections in AIDS patients. B.Sc. in Zoology and Diploma in Medical Laboratory Technology (DMLT).

📍 Global Contributions:

🇸🇦 Saudi Arabia: Active involvement in academia and diagnostics at Majmaah University. 🇮🇳 India: Distinguished Adjunct Professor at Saveetha University, Chennai.

🌐 International Recognition:

External Examiner: All India Institute of Medical Technologists, Kolkata.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 1,046.
  • Citations – 938.
  • h-index – 15.
  • Documents – 39.

A prolific researcher making meaningful contributions to the academic world!

Research Focus: 🧬

Prof. Suresh Mickymaray stands as a prominent figure in the scientific community, particularly excelling in the fields of Medicinal Nanoparticles and Antimicrobial Agents. His groundbreaking work includes the synthesis of gold nanoparticles from Catharanthus roseus, cited 377 times in 2019, demonstrating its potential in inducing caspase-mediated apoptosis in cervical cancer cells (HeLa). His impactful contributions extend to the exploration of flavonoids, with a focus on their anti-fungal efficacy and mechanisms, cited by 268 in 2020. Prof. Mickymaray’s research portfolio encompasses the evaluation of traditional medicinal plants and bioactive compounds against clinically important pathogens, earning 133 citations in 2019. In the realm of cancer research, his work on Rhaponticin’s suppression of osteosarcoma through the inhibition of the PI3K-Akt-mTOR pathway, cited 57 times in 2021, reflects his dedication to advancing therapeutic strategies against cancer. Prof. Suresh Mickymaray’s extensive contributions epitomize his commitment to advancing scientific knowledge for the betterment of healthcare. 🌐🔬

Publications Top Note:

Prof. Funan Liu | Nanobiotechnology

Published on by Global Nano Awards
Prof. Funan Liu: Oncolytic Virus

Congratulations, Prof. Funan Liu, on winning the esteemed Best Researcher Award from ScienceFather! Congratulations on reaching this significant milestone in your journey. Over the past year, you’ve undoubtedly achieved incredible feats and contributed immensely to your field. Here’s to many more years of success, innovation, and fulfillment in your endeavors. Wishing you continued growth, prosperity, and joy in the years to come. Keep shining and making a difference in the world!

Dr. Funan Liu is a distinguished medical professional, serving as a Professor, Chief Physician, and Doctoral Supervisor. Recognized as a key figure in healthcare, he holds prestigious positions as a Youth Top Talent under Liaoning Province’s ‘Revitalize Liaoning Talent Program’ and China Medical University’s Youth Top Talent. Additionally, he is a candidate in the ‘Hundred Thousand Ten Thousand Talent Project’ at the Thousand-Level. Dr. Liu serves as the Chief of the Phase I Clinical Trial Center at the First Affiliated Hospital of China Medical University. His expertise and leadership contribute significantly to advancing medical research and clinical trials, making him a prominent figure in the field.

Major academic positions:  

As the Deputy Director of the Gastric Cancer Committee for the Chinese Society for the Promotion of Health Science and Technology, Dr. Funan Liu plays a pivotal role in advancing gastric cancer research and awareness. He holds several leadership positions, including Vice Chairman of the 10th Committee of the Surgical Branch in the Liaoning Medical Association, and Standing Committee Member of various prestigious organizations, such as the Integrative Oncology Branch of the Chinese Anti-Cancer Association. Dr. Liu is actively involved in committees related to esophageal cancer, tumor prevention and control, oncology, and colorectal cancer. His extensive engagement underscores his commitment to multidisciplinary collaboration and advancing cancer care in various capacities within medical associations and committees.

Undertaken projects:

Dr. Funan Liu, a prominent researcher and medical professional, has spearheaded numerous groundbreaking projects in the realm of oncology. As a principal investigator, he led two National Key R&D Program research initiatives, focusing on clinical trials and therapeutic mechanisms of novel oncolytic virus cancer treatments, and the clinical evaluation of an in vitro tumor cell drug sensitivity technology system. Simultaneously, Dr. Liu undertook two National Natural Science Foundation of China general projects, investigating pH-sensitive liposome-hybrid red blood cell membrane-coated oncolytic virus intravenous delivery technology and the role of FN1 3’UTR as a new ceRNA in gastric cancer. His comprehensive expertise extends to projects funded by Liaoning Province and the CSCO-Merck Serono Cancer Research Fund, solidifying his impactful contributions to advancing cancer research and treatment.

Hosted and participated in clinical research:

This extensive portfolio of clinical trials reflects a commitment to advancing medical science and improving patient outcomes across various oncological fronts. Driven by cutting-edge research, these trials span from Phase I to Phase III, covering a spectrum of investigational therapies for different types of advanced solid tumors. The studies explore innovative approaches such as immunotherapy combinations, targeted therapies, and novel agents, aiming to enhance treatment efficacy and patient survival. From evaluating the safety, tolerability, and pharmacokinetics of promising compounds like TIRAGOLUMAB and DN015089 to studying the potential benefits of combining checkpoint inhibitors with chemotherapy in gastric cancer (HLX10 trial), these trials address critical gaps in current cancer care.

The diversity of trials encompasses indications like breast cancer, colorectal cancer, gastric cancer, and more, reflecting a comprehensive strategy to combat a range of malignancies. The focus on specific genetic mutations, such as EGFR in cholangiocarcinoma and bladder cancer (AL8326 trial), underscores the importance of personalized medicine in tailoring treatments to individual patient profiles. Additionally, the exploration of novel agents like BC004 injection and TJ033721 reveals a dedication to identifying and developing innovative therapeutic modalities.

These studies not only aim to expand the armamentarium of available treatments but also contribute valuable insights to the evolving landscape of cancer research. By pushing the boundaries of scientific understanding, these clinical trials under the leadership of Dr. Funan Liu hold great promise in shaping the future of oncology and, ultimately, improving the lives of patients grappling with advanced solid tumors.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 1,206.
  • Citations – 1,070.
  • h-index – 22.
  • Documents – 55.

A prolific researcher making meaningful contributions to the academic world!

Publications Top Note:
  1. Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy
    • Published in Nature Communications in 2023 with 6 citations.
  2. Virus-Protein Corona Replacement Strategy to Improve the Antitumor Efficacy of Intravenously Injected Oncolytic Adenovirus
    • Published in ACS Nano in 2023 with 0 citations.
  3. Antigen-capturing oncolytic adenoviruses along with IDO blockade for improved tumor immunotherapy
  4. Inhibition of Tumor Metastasis by Liquid-Nitrogen-Shocked Tumor Cells with Oncolytic Viruses Infection
    • Published in Advanced Materials in 2023 with 4 citations.
  5. Oncolytic Virus-Driven Biotherapies from Bench to Bedside
    • Published in Small in 2023 with 2 citations.
  6. Self-assembled short peptides: Recent advances and strategies for potential pharmaceutical applications
    • Published in Materials Today in 2023 with 3 citations.
  7. Erythrocyte-Leveraged Oncolytic Virotherapy (ELeOVt): Oncolytic Virus Assembly on Erythrocyte Surface to Combat Pulmonary Metastasis and Alleviate Side Effects
    • Published in Advanced Science in 2023 with 0 citations.
  8. FN1 mRNA 3′-UTR supersedes traditional fibronectin 1 in facilitating the invasion and metastasis of gastric cancer through the FN1 3′-UTR-let-7i-5p-THBS1 axis
    • Published in Theranostics in 2023 with 0 citations.
  9. Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis
    • Published in Frontiers in Pharmacology in 2023 with 2 citations.
  10. Drug conjugate-based anticancer therapy – Current status and perspectives
    • Published in Cancer Letters in 2023 with 17 citations.